Drug class
Thrombopoietin Receptor Agonist
Mechanism of action
Thrombopoietin Receptor Agonists
General use cases
- Anemia, Aplastic
- Purpura, Thrombocytopenic, Idiopathic
- patients with myelodysplastic syndrome (MDS)
- thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy
- thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
